Publication: Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations
Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations
Date
Date
Date
Citations
Barrow, J. J., Balsa, E., Verdeguer, F., Tavares, C. D. J., Soustek, M. S., Hollingsworth, L. R., Jedrychowski, M., Vogel, R., Paulo, J. A., Smeitink, J., Gygi, S. P., Doench, J., Root, D. E., & Puigserver, P. (2016). Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations. Molecular Cell, 64(1), 163–175. https://doi.org/10.1016/j.molcel.2016.08.023
Abstract
Abstract
Abstract
Mitochondrial diseases comprise a heterogeneous group of genetically inherited disorders that cause failures in energetic and metabolic function. Boosting residual oxidative phosphorylation (OXPHOS) activity can partially correct these failures. Herein, using a high-throughput chemical screen, we identified the bromodomain inhibitor I-BET 525762A as one of the top hits that increases COX5a protein levels in complex I (CI) mutant cybrid cells. In parallel, bromodomain-containing protein 4 (BRD4), a target of I-BET 525762A, was identifi
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Barrow, J. J., Balsa, E., Verdeguer, F., Tavares, C. D. J., Soustek, M. S., Hollingsworth, L. R., Jedrychowski, M., Vogel, R., Paulo, J. A., Smeitink, J., Gygi, S. P., Doench, J., Root, D. E., & Puigserver, P. (2016). Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations. Molecular Cell, 64(1), 163–175. https://doi.org/10.1016/j.molcel.2016.08.023